Repository logo
 
Loading...
Thumbnail Image
Publication

Oligophrenin-1 (OPHN1), a gene involved in X-linked intellectual disability, undergoes RNA editing and alternative splicing during human brain development

Use this identifier to reference this record.
Name:Description:Size:Format: 
journal.pone.0091351.pdf1.49 MBAdobe PDF Download

Advisor(s)

Abstract(s)

Oligophrenin-1 (OPHN1) encodes for a Rho-GTPase-activating protein, important for dendritic morphogenesis and synaptic function. Mutations in this gene have been identified in patients with X-linked intellectual disability associated with cerebellar hypoplasia. ADAR enzymes are responsible for A-to-I RNA editing, an essential post-transcriptional RNA modification contributing to transcriptome and proteome diversification. Specifically, ADAR2 activity is essential for brain development and function. Herein, we show that the OPHN1 transcript undergoes post-transcriptional modifications such as A-to-I RNA editing and alternative splicing in human brain and other tissues. We found that OPHN1 editing is detectable already at the 18th week of gestation in human brain with a boost of editing at weeks 20 to 33, concomitantly with OPHN1 expression increase and the appearance of a novel OPHN1 splicing isoform. Our results demonstrate that multiple post-transcriptional events occur on OPHN1, a gene playing an important role in brain function and development.

Description

Keywords

RNA editing Brain Development

Citation

Barresi S, Tomaselli S, Athanasiadis A, Galeano F, Locatelli F, et al. (2014) Oligophrenin-1 (OPHN1) , a Gene Involved in X-Linked Intellectual Disability, Undergoes RNA Editing and Alternative Splicing during Human Brain Development. PLoS ONE 9(3): e91351. doi:10.1371/journal.pone.0091351

Research Projects

Organizational Units

Journal Issue

Publisher

PLOS

Collections

CC License

Altmetrics